{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:44:16Z","timestamp":1790858656386,"version":"4.1.0"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Luteolin, a flavonoid naturally present in a variety of fruits, vegetables, and medicinal plants, has been recognized as a potentially effective neuroprotective nutraceutical because of its remarkable anti-inflammatory, antioxidant, and neurotrophic properties. Increasing evidence suggests that neuroinflammation and oxidative stress are major contributors to cognitive decline and neuronal degeneration in several prominent neurodegenerative disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and multiple sclerosis (MS). Luteolin significantly inhibits microglial activation, reduces pro-inflammatory cytokine production, modulates the nuclear factor kappa B (NF-\u03baB) and mitogen-activated protein kinase (MAPK) signaling pathways, and enhances Nrf2-mediated antioxidant mechanisms. Furthermore, it promotes synaptic plasticity through brain-derived neurotrophic factor (BDNF)-associated pathways and mitigates the aggregation of pathological proteins, including A\u03b2, tau, \u03b1-synuclein, and mutant huntingtin. Preclinical studies consistently demonstrate substantial improvements in cognitive function, motor performance, demyelination, and neuronal viability in models of AD, PD, MS, and HD. Preliminary clinical observations also indicate prospective advantages for cognitive function, regulation of inflammatory responses, and alleviation of symptoms, particularly concerning AD and MS. Notwithstanding these encouraging outcomes, obstacles persist due to luteolin's restricted bioavailability, ideal dosing parameters, and the translational discrepancies between experimental models and human pathophysiological conditions. In summary, luteolin emerges as a noteworthy candidate for nutraceutical-oriented approaches designed to alleviate neuroinflammation and cognitive deterioration in the context of neurodegenerative diseases.<\/jats:p>","DOI":"10.3389\/fnut.2026.1774416","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T05:34:09Z","timestamp":1775540049000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Luteolin as a dietary flavonoid for brain health: modulating neuroinflammation and cognitive decline in neurodegenerative disorders"],"prefix":"10.3389","volume":"13","author":[{"given":"Huanglei","family":"Jiang","sequence":"first","affiliation":[{"name":"Chinese Medicine Hospital of Tiantai County","place":["Taizhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu'e","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tiantai People's Hospital of Zhejiang Province, Tiantai Branch of Zhejiang Provincial People's Hospital, Hangzhou Medical College","place":["Taizhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","unstructured":"Global Status Report on the Public Health Response to Dementia\n          \n          2021","DOI":"10.1016\/S2468-2667(21)00215-2"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1201\/9781003464648","volume-title":"Synaptic Plasticity in Neurodegenerative Disorders","author":"Singh","year":"2024"},{"key":"B4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.arr.2016.09.010","article-title":"Nutrition for the ageing brain: towards evidence for an optimal diet","volume":"35","author":"Vauzour","year":"2017","journal-title":"Ageing Res Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1017\/S0029665117004177","article-title":"Diet, nutrition and the ageing brain: current evidence and new directions","volume":"77","author":"Moore","year":"2018","journal-title":"Proc Nutr Soc."},{"key":"B6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2174\/187152410793429728","article-title":"Neuroprotection by natural polyphenols: molecular mechanisms","volume":"10","author":"Campos-Esparza Mdel","year":"2010","journal-title":"Cent Nerv Syst Agents Med Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.3390\/molecules28145415","article-title":"Polyphenols and neurodegenerative diseases: potential effects and mechanisms of neuroprotection","volume":"28","author":"Arias-S\u00e1nchez","year":"2023"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.intimp.2011.03.012","article-title":"Anti-inflammatory activity of structurally related flavonoids, apigenin, luteolin and fisetin","volume":"11","author":"Funakoshi-Tago","year":"2011","journal-title":"Int Immunopharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e23482","DOI":"10.1002\/jbt.23482","article-title":"From nature to therapy: luteolin's potential as an immune system modulator in inflammatory disorders","volume":"37","author":"Hussain","year":"2023","journal-title":"J Biochem Mol Toxicol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2015.09.002","article-title":"Luteolin as an anti-inflammatory and neuroprotective agent: a brief review","volume":"119","author":"Nabavi","year":"2015","journal-title":"Brain Res Bull."},{"key":"B11","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s43440-024-00610-8","article-title":"Luteolin for neurodegenerative diseases: a review","volume":"76","author":"Jayawickreme","year":"2024","journal-title":"Pharmacol Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1002\/tox.23903","article-title":"Luteolin\/ZnO nanoparticles attenuate neuroinflammation associated with diabetes via regulating MicroRNA-124 by targeting C\/EBPA","volume":"38","author":"Moustafa","year":"2023","journal-title":"Environ Toxicol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/biof.1687","article-title":"Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma","volume":"47","author":"Kempuraj","year":"2021","journal-title":"Biofactors."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1017\/jns.2016.41","article-title":"Flavonoids: an overview","volume":"5","author":"Panche","year":"2016","journal-title":"J Nutr Sci."},{"key":"B15","unstructured":"Ibrahim\n              IM\n            \n          \n          Luteolin: A Comprehensive Review of its Chemical Properties, Biological Activities, and Therapeutic Potential\n          \n          2025"},{"key":"B16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/ajcn\/79.5.727","article-title":"Polyphenols: food sources and bioavailability","volume":"79","author":"Manach","year":"2004","journal-title":"Am J Clin Nutr."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22573\/spg.ijals.017.s12200084","article-title":"Food based phytochemical luteolin their derivatives, sources and medicinal benefits","volume":"3","author":"Manzoor","year":"2017","journal-title":"Int J Agric Life Sci IJAL."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e12579","DOI":"10.1111\/jfbc.12579","article-title":"Analysis of rutin, \u03b2-carotene, and lutein content and evaluation of antioxidant activities of six edible leaves on free radicals and reactive oxygen species","volume":"42","author":"Gunathilake","year":"2018","journal-title":"J Food Biochem."},{"key":"B19","volume-title":"Phenolic Compounds: Classification, Chemistry, and Updated Techniques of Analysis and Synthesis","author":"Al","year":"2021"},{"key":"B20","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.freeradbiomed.2004.01.002","article-title":"Absorption and metabolism of flavonoids","volume":"36","author":"Walle","year":"2004","journal-title":"Free Radic Biol Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"7730","DOI":"10.1080\/10408398.2021.1917508","article-title":"Absorption, metabolism and bioavailability of flavonoids: a review","volume":"62","author":"Chen","year":"2022","journal-title":"Crit Rev Food Sci Nutr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1080\/10408398.2021.1947772","article-title":"Enhancement of bioavailability and bioactivity of diet-derived flavonoids by application of nanotechnology: a review","volume":"63","author":"Teng","year":"2023","journal-title":"Crit Rev Food Sci Nutr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jff.2017.05.056","article-title":"Pharmacokinetics, tissue distribution and excretion of luteolin and its major metabolites in rats: metabolites predominate in blood, tissues and are mainly excreted via bile","volume":"35","author":"Deng","year":"2017","journal-title":"J Funct Foods."},{"key":"B24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3109\/00207454.2011.569040","article-title":"Luteolin inhibits microglial inflammation and improves neuron survival against inflammation","volume":"121","author":"Zhu LH Bi","year":"2011","journal-title":"Int J Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1007\/s12640-021-00426-x","article-title":"Luteolin suppresses microglia neuroinflammatory responses and relieves inflammation-induced cognitive impairments","volume":"39","author":"Zhou","year":"2021","journal-title":"Neurotox Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1016\/j.fct.2007.05.015","article-title":"Critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic\/carcinogenic properties","volume":"45","author":"Harwood","year":"2007","journal-title":"Food Chem Toxicol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"7707","DOI":"10.1038\/s41598-024-57824-2","article-title":"Neuroprotective mechanisms of luteolin in glutamate-induced oxidative stress and autophagy-mediated neuronal cell death","volume":"14","author":"Vongthip","year":"2024","journal-title":"Sci Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13020-025-01204-z","article-title":"Potential of phytochemicals in the treatment of Alzheimer disease by modulating lysosomal dysfunction: a systematic review","volume":"20","author":"Yuan","year":"2025","journal-title":"Chin Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"106727","DOI":"10.1016\/j.intimp.2020.106727","article-title":"A network pharmacology strategy to investigate the anti-inflammatory mechanism of luteolin combined with in vitro transcriptomics and proteomics","volume":"86","author":"Huang","year":"2020","journal-title":"Int Immunopharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1055\/s-0028-1088314","article-title":"Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin","volume":"74","author":"Seelinger","year":"2008","journal-title":"Planta Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"352","DOI":"10.2174\/1871527318666190319141835","article-title":"Bioavailability and pharmaco-therapeutic potential of luteolin in overcoming alzheimer's disease","volume":"18","author":"Ali","year":"2019","journal-title":"CNS Neurol Disord Drug Targets."},{"key":"B32","doi-asserted-by":"publisher","first-page":"112236","DOI":"10.1016\/j.biopha.2021.112236","article-title":"Antioxidant properties of flavonoid metal complexes and their potential inclusion in the development of novel strategies for the treatment against neurodegenerative diseases","volume":"143","author":"Rodr\u00edguez-Arce","year":"2021","journal-title":"Biomed Pharmacother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"984","DOI":"10.2174\/1871527323666230912090856","article-title":"Role of BDNF signaling in the neuroprotective and memory-enhancing effects of flavonoids in alzheimer's disease","volume":"23","author":"Amidfar","year":"2024","journal-title":"CNS Neurol Disord Drug Targets."},{"key":"B34","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/brainsci15030252","article-title":"Phytochemicals targeting BDNF signaling for treating neurological disorders","volume":"15","author":"Singh","year":"2025","journal-title":"Brain Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"72","DOI":"10.12944\/CRNFSJ.13.Special-Issue-July.05","article-title":"Phytonutrients in neuroprotection and neurodegenerative disorders","volume":"13","author":"Kumar","year":"2025","journal-title":"Curr Res Nutr Food Sci J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"101097","DOI":"10.1016\/j.jpha.2024.101097","article-title":"Luteolin and its antidepressant properties: from mechanism of action to potential therapeutic application","volume":"15","author":"Zhou","year":"2025","journal-title":"J Pharm Anal."},{"key":"B37","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.1002\/ptr.70018","article-title":"Flavonoids being chemo-preventive agents induce programmed cell death: mechanisms and therapeutic potentials","volume":"39","author":"Nawaz","year":"2025","journal-title":"Phytother Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell."},{"key":"B39","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3390\/ijms15010895","article-title":"Luteolin reduces alzheimer's disease pathologies induced by traumatic brain injury","volume":"15","author":"Sawmiller","year":"2014","journal-title":"Int J Mol Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"102848","DOI":"10.1016\/j.redox.2023.102848","article-title":"Protective effects of luteolin against amyloid beta-induced oxidative stress and mitochondrial impairments through peroxisome proliferator-activated receptor \u03b3-dependent mechanism in alzheimer's disease","volume":"66","author":"He","year":"2023","journal-title":"Redox Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e20240204","DOI":"10.1590\/1980-5764-dn-2024-0204","article-title":"Advancements in the treatment of alzheimer's disease: a comprehensive review","volume":"19","author":"Rajanna","year":"2025","journal-title":"Dement Neuropsychol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"110011","DOI":"10.1016\/j.jnutbio.2025.110011","article-title":"Untargeted metabolomics reveals the mechanisms of luteolin and exercise combination treatment against cognitive impairments in AD mice through modulating autophagy","volume":"145","author":"Tao","year":"2025","journal-title":"J Nutr Biochem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e14914","DOI":"10.1111\/cns.14914","article-title":"Investigating the effects of Ginkgo biloba leaf extract on cognitive function in alzheimer's disease","volume":"30","author":"Zhu","year":"2024","journal-title":"CNS Neurosci Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3233\/JAD-220904","article-title":"Luteolin and exercise combination therapy ameliorates amyloid-\u03b21-42 oligomers-induced cognitive impairment in AD mice by mediating neuroinflammation and autophagy","volume":"92","author":"Tao","year":"2023","journal-title":"J Alzheimers Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3390\/biomedicines10061236","article-title":"Co-ultramicronized palmitoylethanolamide\/luteolin restores oligodendrocyte homeostasis via peroxisome proliferator-activated receptor-\u03b1 in an in vitro model of alzheimer's disease","volume":"10","author":"Facchinetti","year":"2022","journal-title":"Biomedicines."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3390\/pharmaceutics14051003","article-title":"Novel luteolin-loaded chitosan decorated nanoparticles for brain-targeting delivery in a sporadic alzheimer's disease mouse model: focus on antioxidant, anti-inflammatory, and amyloidogenic pathways","volume":"14","author":"Abbas","year":"2022","journal-title":"Pharmaceutics"},{"key":"B47","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3390\/pharmaceutics14030576","article-title":"A brain-targeted approach to ameliorate memory disorders in a sporadic alzheimer's disease mouse model via intranasal luteolin-loaded nanobilosomes","volume":"14","author":"Elsheikh","year":"2022","journal-title":"Pharmaceutic"},{"key":"B48","doi-asserted-by":"publisher","first-page":"780602","DOI":"10.3389\/fnagi.2022.780602","article-title":"Synergistic combination of dha, luteolin, and urolithin a against alzheimer's disease","volume":"14","author":"Jayatunga","year":"2022","journal-title":"Front Aging Neurosci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"9583","DOI":"10.3390\/ijms22179583","article-title":"Deciphering the potential neuroprotective effects of luteolin against a\u03b2(1)-(42)-induced alzheimer's disease","volume":"22","author":"Ahmad","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B50","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41401-021-00702-8","article-title":"Luteolin alleviates cognitive impairment in Alzheimer's disease mouse model via inhibiting endoplasmic reticulum stress-dependent neuroinflammation","volume":"43","author":"Kou","year":"2022","journal-title":"Acta Pharmacol Sin."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.3390\/molecules26071996","article-title":"Deciphering the interactions of bioactive compounds in selected traditional medicinal plants against alzheimer's diseases via pharmacophore modeling, auto-QSAR, and molecular docking approaches","volume":"26","author":"Ojo","year":"2021","journal-title":"Molecules"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2861978","DOI":"10.1155\/2020\/2861978","article-title":"Luteolin protects pheochromocytoma (PC-12) cells against A\u03b2 (25-35)-induced cell apoptosis through the ER\/ERK\/MAPK signalling pathway","volume":"2020","author":"Wang","year":"2020","journal-title":"Evid Based Complement Alternat Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.nutres.2018.09.010","article-title":"The combination of luteolin and l-theanine improved alzheimer disease-like symptoms by potentiating hippocampal insulin signaling and decreasing neuroinflammation and norepinephrine degradation in amyloid-\u03b2-infused rats","volume":"60","author":"Park","year":"2018","journal-title":"Nutr Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neulet.2018.10.053","article-title":"Therapeutic potential of luteolin in transgenic drosophila model of alzheimer's disease","volume":"692","author":"Ali","year":"2019","journal-title":"Neurosci Lett"},{"key":"B55","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.3892\/mmr.2016.5052","article-title":"Ameliorating effect of luteolin on memory impairment in an alzheimer's disease model","volume":"13","author":"Wang","year":"2016","journal-title":"Mol Med Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.2174\/1871527313666140806124322","article-title":"Neuroprotection by association of palmitoylethanolamide with luteolin in experimental alzheimer's disease models: the control of neuroinflammation","volume":"13","author":"Paterniti","year":"2014","journal-title":"CNS Neurol Disord Drug Targets."},{"key":"B57","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12993-025-00279-w","article-title":"Neurodegeneration models in parkinson's disease: cellular and molecular paths to neuron death","volume":"21","author":"\u00c1lvarez-Luqu\u00edn","year":"2025","journal-title":"Behav Brain Funct."},{"key":"B58","doi-asserted-by":"publisher","first-page":"177829","DOI":"10.1016\/j.ejphar.2025.177829","article-title":"Therapeutic potential of flavonoids against \u03b1-synuclein aggregation in parkinson's disease: integrative in silico and in vitro analysis","volume":"1002","author":"Khorsand","year":"2025","journal-title":"Eur J Pharmacol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s13205-025-04267-9","article-title":"Targeting dopaminergic neuronal death: luteolin as a therapeutic modulator in parkinson's disease","volume":"15","author":"Chib","year":"2025","journal-title":"3 Biotech."},{"key":"B60","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s13205-025-04224-6","article-title":"Exploring therapeutic potential of bacopa monnieri bioactive compounds against alzheimer's and parkinson's diseases","volume":"15","author":"Shukla","year":"2025","journal-title":"3 Biotech."},{"key":"B61","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1089\/rej.2024.0045","article-title":"Luteolin exhibits anxiolytic and antidepressant potential in parkinson's disease rat: antioxidant and anti-inflammatory effects","volume":"28","author":"She","year":"2025","journal-title":"Rejuvenation Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"110196","DOI":"10.1016\/j.isci.2024.110196","article-title":"The HRD1-SEL1L ubiquitin ligase regulates stress granule homeostasis in couple with distinctive signaling branches of ER stress","volume":"27","author":"Shi","year":"2024","journal-title":"iScience."},{"key":"B63","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11064-023-04019-2","article-title":"Luteolin protects against 6-hydoroxydopamine-induced cell death via an upregulation of HRD1 and SEL1L","volume":"49","author":"Nishiguchi","year":"2024","journal-title":"Neurochem Res."},{"key":"B64","first-page":"75","article-title":"Camptocormia in parkinson's disease: definition, epidemiology, pathogenesis and treatment modalities","volume":"87","author":"Srivanitchapoom","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B65","first-page":"12","article-title":"Palmitoylethanolamide\/Luteolin as adjuvant therapy to improve an unusual case of camptocormia in a patient with parkinson's disease: a case report","volume":"18","author":"Brotini","year":"2021","journal-title":"Innov Clin Neurosci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3390\/molecules24071435","article-title":"Dereplication of components coupled with HPLC-qTOF-MS in the active fraction of humulus japonicus and it's protective effects against parkinson's disease mouse model","volume":"24","author":"Lee","year":"2019","journal-title":"Molecules"},{"key":"B67","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/01480545.2018.1504961","article-title":"Luteolin protects microglia against rotenone-induced toxicity in a hormetic manner through targeting oxidative stress response, genes associated with Parkinson's disease and inflammatory pathways","volume":"43","author":"Elmazoglu","year":"2020","journal-title":"Drug Chem Toxicol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.2174\/1871527314666150821102823","article-title":"The association of palmitoylethanolamide with luteolin decreases neuroinflammation and stimulates autophagy in parkinson's disease model","volume":"14","author":"Siracusa","year":"2015","journal-title":"CNS Neurol Disord Drug Targets."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22074\/cellj.2016.4867","article-title":"Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy","volume":"19","author":"Ghasemi","year":"2017","journal-title":"Cell J."},{"key":"B70","doi-asserted-by":"publisher","first-page":"115781","DOI":"10.1016\/j.ab.2025.115781","article-title":"Identification of lipid metabolism-related gene markers and construction of a diagnostic model for multiple sclerosis: An integrated analysis by bioinformatics and machine learning","volume":"700","author":"Yang","year":"2025","journal-title":"Anal Biochem."},{"key":"B71","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1742-2094-6-28","article-title":"Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta","volume":"6","author":"Sternberg","year":"2009","journal-title":"J Neuroinflammation."},{"key":"B72","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature25502","article-title":"The cryo-electron microscopy structure of huntingtin","volume":"555","author":"Guo","year":"2018","journal-title":"Nature."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e70025","DOI":"10.1111\/cns.70025","article-title":"Luteolin as potential treatment for huntington's disease: insights from a transgenic mouse model","volume":"30","author":"Mohammed","year":"2024","journal-title":"CNS Neurosci Ther."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2015.10.004","article-title":"Protective effects of 3-alkyl luteolin derivatives are mediated by Nrf2 transcriptional activity and decreased oxidative stress in Huntington's disease mouse striatal cells","volume":"91","author":"Oliveira","year":"2015","journal-title":"Neurochem Int."},{"key":"B75","doi-asserted-by":"publisher","first-page":"100148","DOI":"10.1016\/j.comtox.2020.100148","article-title":"Effect of luteolin on the transgenic drosophila model of huntington's disease","volume":"17","author":"Siddique","year":"2021","journal-title":"Comput Toxicol."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1774416\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T05:34:12Z","timestamp":1775540052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1774416\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":75,"alternative-id":["10.3389\/fnut.2026.1774416"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1774416","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"article-number":"1774416"}}